Literature DB >> 10063699

Onchocerciasis.

F O Richards1, E Miri, S Meredith, R Guderian, M Sauerbrey, H Remme, R Packard, J M Ndiaye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10063699      PMCID： PMC2305701     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  11 in total

1.  Ethical issues in funding orphan drug research and development.

Authors:  C A Gericke; A Riesberg; R Busse
Journal:  J Med Ethics       Date:  2005-03       Impact factor: 2.903

2.  Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

Authors:  M Lizotte-Waniewski; W Tawe; D B Guiliano; W Lu; J Liu; S A Williams; S Lustigman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.

Authors:  C S Mai; D M Hamm; M Banla; A Agossou; H Schulz-Key; C Heuschkel; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

4.  Detection of Onchocerca volvulus in Skin Snips by Microscopy and Real-Time Polymerase Chain Reaction: Implications for Monitoring and Evaluation Activities.

Authors:  Elizabeth A Thiele; Vitaliano A Cama; Thomson Lakwo; Sindeaw Mekasha; Francisca Abanyie; Markos Sleshi; Amha Kebede; Paul T Cantey
Journal:  Am J Trop Med Hyg       Date:  2016-02-15       Impact factor: 2.345

5.  One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone.

Authors:  Frank Richards; Nidia Rizzo; Carlos Enrique Diaz Espinoza; Zoraida Morales Monroy; Carol Guillermina Crovella Valdez; Renata Mendizabal de Cabrera; Oscar de Leon; Guillermo Zea-Flores; Mauricio Sauerbrey; Alba Lucia Morales; Dalila Rios; Thomas R Unnasch; Hassan K Hassan; Robert Klein; Mark Eberhard; Ed Cupp; Alfredo Domínguez
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

Review 6.  Broadening the range of use cases for ivermectin - a review of the evidence.

Authors:  Christian Kositz; John Bradley; Harry Hutchins; Anna Last; Umberto D'Alessandro; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-03-02       Impact factor: 2.455

7.  Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin.

Authors:  Alexander Yaw Debrah; Sabine Mand; Yeboah Marfo-Debrekyei; John Larbi; Ohene Adjei; Achim Hoerauf
Journal:  Filaria J       Date:  2006-02-05

8.  Anti-Onchocerca activity and phytochemical analysis of an essential oil from Cyperus articulatus L.

Authors:  Jonathan Alunge Metuge; Kennedy D Nyongbela; James A Mbah; Moses Samje; Ghislain Fotso; Smith B Babiaka; Fidelis Cho-Ngwa
Journal:  BMC Complement Altern Med       Date:  2014-07-07       Impact factor: 3.659

9.  Filaricidal properties of Lantana camara and Tamarindus indica extracts, and Lantadene A from L. camara against Onchocerca ochengi and Loa loa.

Authors:  Adela Ngwewondo; Meng Wang; Faustin Pascal T Manfo; Moses Samje; Jessie N'kam Ganin's; Emmanuel Ndi; Raymond J Andersen; Fidelis Cho-Ngwa
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13

10.  The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria.

Authors:  Frank O Richards; Abel Eigege; John Umaru; Barminas Kahansim; Solomon Adelamo; Jonathan Kadimbo; Jacob Danboyi; Hayward Mafuyai; Yisa Saka; Gregory S Noland; Chukwuma Anyaike; Michael Igbe; Lindsay Rakers; Emily Griswold; Thomas R Unnasch; B E B Nwoke; Emmanuel Miri
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 3.707
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.